NantHealth Inc (NH)

4.28
0.04 0.94
NASDAQ : Technology
Prev Close 4.24
Open 4.28
Day Low/High 4.17 / 4.37
52 Wk Low/High 10.91 / 21.00
Volume 117.14K
Avg Volume 227.20K
Exchange NASDAQ
Shares Outstanding 121.96M
Market Cap 528.10M
EPS -1.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

NantHealth Reports 2017 Second Quarter Financial Results; Implements Plan To Focus On Core Competencies, Enhance Profitability And Position For Growth Of Artificial Intelligence For Cancer Care

NantHealth Reports 2017 Second Quarter Financial Results; Implements Plan To Focus On Core Competencies, Enhance Profitability And Position For Growth Of Artificial Intelligence For Cancer Care

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its second quarter ended June 30, 2017.

NantHealth To Report 2017 Second-Quarter Financial Results And Host Conference Call On Thursday, August 10

NantHealth To Report 2017 Second-Quarter Financial Results And Host Conference Call On Thursday, August 10

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2017 second quarter on Thursday, August 10, 2017, after...

NantHealth Continues Global Expansion Of GPS Cancer™ By Bringing Advanced Genomic Profiling To Patients In Mexico

NantHealth Continues Global Expansion Of GPS Cancer™ By Bringing Advanced Genomic Profiling To Patients In Mexico

NantHealth, Inc. (Nasdaq: NH), a leading next-generation, evidence-based, personalized healthcare company, today announced that GPS Cancer, a molecular test that helps guide cancer treatment strategies...

NantHealth Announces Three-Year Contract Extension With Long-Time Client Blue Cross And Blue Shield Of Nebraska

NantHealth Announces Three-Year Contract Extension With Long-Time Client Blue Cross And Blue Shield Of Nebraska

NantHealth, Inc.(NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that  Blue Cross and Blue Shield of Nebraska (BCBSNE),a NantHealth client since 2010, and...

NantHealth To Present At The Jefferies Healthcare Conference On June 7, 2017

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that the company will present at the Jefferies Healthcare Conference at 4 p.

Scott+Scott, Attorneys At Law, LLP Announces Investigation Into NantHealth, Inc. (NASDAQ: NH)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, announces the commencement of an investigation into NantHealth, Inc.

NantHealth Names Ronald A. Louks As Chief Operating Officer

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced the appointment of Ronald A.

Scott+Scott, Attorneys At Law, LLP Announces Investigation Into NantHealth, Inc. (NASDAQ: NH)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, announces the commencement of an investigation into NantHealth, Inc.

NantHealth Reports 16% Increase In 2017 First Quarter Total Net Revenue; SaaS Revenue Rose 11% And GPS Adoption Continues To Climb

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its first quarter ended March 31, 2017.

NantHealth Appoints Dr. Sandeep Reddy As Chief Medical Officer

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today the appointment of Sandeep (Bobby) Reddy, MD, as Chief Medical Officer.

NantHealth To Report 2017 First-Quarter Financial Results And Host Conference Call On Wednesday, May 10

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2017 first quarter on Wednesday, May 10, 2017, after market...

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In NantHealth, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in NantHealth, Inc.

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of Upcoming May 8th Deadline To File For Lead Plaintiff In Class Action Lawsuit Against NantHealth, Inc. (NASDAQ: NH)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that May 8, 2017 is the last day to petition the court for lead plaintiff status in the...

NantHealth To Present At The Deutsche Bank 42nd Annual HealthCare Conference On May 4, 2017

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that the company will present at the Deutsche Bank 42nd Annual Health Care Conference at 10:40 a.

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In NantHealth, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in NantHealth, Inc.

Discovery's David Zaslav Shows It's Good to Be a Media CEO

Discovery's David Zaslav Shows It's Good to Be a Media CEO

The CEO of the cable network owner made either $37.2 million or $44.7 million in 2016, depending on what's counted, which is still down sharply from $156.1 million in 2014.

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In NantHealth, Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf...

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of NantHealth, Inc.

Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether NantHealth, Inc.

NantHealth Enters Oversold Territory (NH)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Tronc's Latest Fusillade Targeting Soon-Shiong Gets to Core Question

Tronc's Latest Fusillade Targeting Soon-Shiong Gets to Core Question

It's Season Two of the Tronc drama, but the real question is now acknowledged: who will own the Los Angeles Times?

TheStreet Quant Rating: D- (Sell)